Publications
Detailed Information
Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones
Cited 13 time in
Web of Science
Cited 17 time in Scopus
- Authors
- Issue Date
- 2007-03-21
- Publisher
- Wiley-Blackwell
- Citation
- Nephrology (Carlton). 2007 Apr;12(2):113-7.
- Keywords
- Animals ; Arginine Vasopressin/genetics/*metabolism ; COS Cells ; Cell Membrane/metabolism ; Cercopithecus aethiops ; Diabetes Insipidus, Nephrogenic/genetics/*metabolism ; Dimethyl Sulfoxide/*pharmacology ; Humans ; Male ; Methylamines/*pharmacology ; Molecular Chaperones/pharmacology ; Mutation, Missense ; Point Mutation ; Protein Folding ; Protein Transport/drug effects ; Receptors, Vasopressin/chemistry/genetics/*metabolism ; Temperature ; Transfection ; Mutation
- Abstract
- AIM: X-linked nephrogenic diabetes insipidus is a rare disease caused by mutations in the arginine vasopressin V2 receptor (AVPR2) gene, which encodes vasopressin V2 receptor (V2R). More than a half of reported mutations in AVPR2 are missense mutations, and a large number of missense mutant receptors fail to fold properly and therefore are not routed to the cell surface. METHODS: We analysed the AVPR2 gene in 14 unrelated patients with X-linked nephrogenic diabetes insipidus, and found 13 different mutations including eight missense point mutations. The cellular expression patterns of three missense mutant (A98P, L274P and R113W) and wild-type V2R were determined in transfected COS-7 cells. RESULTS: In contrast to wild-type V2R, the cell-surface expressions of mutant receptors were totally (A98P and L274P) or partially (R113W) absent. Instead, they were retained intracellularly. However, treatment of cells with two chemical chaperones (100 mmol/L trimethylamine oxide or 2% dimethyl sulfoxide) or incubation at 26 degrees C restored the cell-surface expressions of mutant receptors. CONCLUSION: These data show that some chemical chaperones correct the mistrafficking of misfolded A98P, L274P and R113W V2R. Thus, we believe that a therapeutic strategy based on chemical chaperones in patients with these mutations is worth trying.
- ISSN
- 1320-5358 (Print)
- Language
- English
- URI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17371330
https://hdl.handle.net/10371/46584
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.